Nautilus Biotechnology In...

NASDAQ: NAUT · Real-Time Price · USD
0.71
-0.01 (-1.63%)
At close: Aug 15, 2025, 1:24 PM

Nautilus Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
27.65M 19.4M 114.52M 185.62M
Short-Term Investments
102.25M 154.02M 69.95M 160.11M
Long-Term Investments
76.41M 90.65M 129.17M 16.37M
Other Long-Term Assets
1.18M 1.18M 1.11M 997K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.93M 3.42M 2.74M 3.49M
Total Current Assets
132.83M 176.84M 187.21M 349.22M
Property-Plant & Equipment
32.33M 36.9M 32.57M 31.86M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
109.92M 128.73M 162.84M 49.23M
Total Assets
242.74M 305.56M 350.05M 398.45M
Account Payables
987K 1.64M 1.27M 1.72M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 1.99M 970K
Other Current Liabilities
2.55M 2.97M 116K 883K
Total Current Liabilities
7.63M 9.12M 6.79M 5.81M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
26.38M 31.09M 28.34M 29.06M
Total Liabilities
34.01M 40.21M 35.13M 34.87M
Total Debt
30.48M 34.63M 30.33M 30.03M
Common Stock
13K 13K 12K 12K
Retained Earnings
-273.02M -202.24M -138.56M -80.64M
Comprehensive Income
57K -255K -1.85M -184K
Shareholders Equity
208.73M 265.35M 314.92M 363.58M
Total Investments
178.65M 244.67M 199.12M 176.48M